Consensus $7.99. Raises FY25 revenue view to up 6.7%-7.7% from 5.7%-8.2%. The company said, “The Company is updating its full-year 2025 financial guidance to tighten full-year 2025 reported, constant currency and organic constant currency revenue guidance and increase adjusted earnings per share financial guidance.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Notable companies reporting before tomorrow’s open
- Zimmer Biomet Holdings (ZBH) Q2 Earnings Cheat Sheet
- Roth MKM medical technology analyst holds analyst/industry conference call
- DoorDash, Southwest downgraded: Wall Street’s top analyst calls
- Zimmer Biomet’s Strategic Acquisition of Monogram: A Hold Rating Amid Integration and Market Challenges